# FDA recall D-0898-2017

> **Hospira Inc., A Pfizer Company** · Class II · drug recall initiated 2017-05-18.

## Product

Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only,  Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04

## Reason for recall

GMP Deviation; A foreign stopper was observed during packaging of a lot of product.

## Distribution

Nationwide, Canada and Singapore

## Key facts

- **Recall number:** D-0898-2017
- **Recalling firm:** Hospira Inc., A Pfizer Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-05-18
- **Report date:** 2017-06-21
- **Termination date:** 2019-05-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0898-2017

## Citation

> AI Analytics. FDA recall D-0898-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0898-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*